Previous 10 | Next 10 |
Inspire Medical Systems (NYSE: INSP ) initiated with Overweight rating and $74 (19% upside) price target at Piper Sandler. More news on: Inspire Medical Systems, Inc., Prevail Therapeutics Inc., Stereotaxis, Inc., Healthcare stocks news, Stocks on the move, , Read more ...
BioNano Genomics (NASDAQ: BNGO ) initiated with Outperform rating and $1.50 (443% upside) price target at Oppenheimer. Shares up 19% premarket. More news on: Bionano Genomics, Inc., NovoCure Limited, Regeneron Pharmaceuticals, Inc., Healthcare stocks news, Stocks on the move, ,...
SYDNEY , April 2, 2020 /PRNewswire/ -- The Icon Cancer Centre Wahroonga in Australia has treated its first cancer patient with Varian Ethos™. This artificial intelligence (AI)-driven holistic adaptive therapy solution is designed to deliver an entire adapted treatment i...
Apellis Pharmaceuticals (NASDAQ: APLS ) initiated with Strong Buy rating and $86 (221% upside) price target at Raymond James. More news on: Apellis Pharmaceuticals, Inc., BioXcel Therapeutics, Inc., Eidos Therapeutics, Inc., Healthcare stocks news, Stocks on the move, , Read more ...
PALO ALTO, Calif. , March 31, 2020 /PRNewswire/ -- Highlights RapidPlan PT is the first clinical application of machine learning in proton treatment planning RT Peer Review is designed to streamline and accelerate the radiation therapy peer review process Eclipse v16 has receiv...
New York City, NY:March 27, 2020 – Published via (Wired Release) – Recent Research and Future Market Potential of Cyber Knife Market in Global Industry: 2020 Research and New Innovations in Medical Devices Sector. The prime objective of the report is to offer updates and informat...
New York City, NY:March 26, 2020 – Published via (Wired Release) – Recent Research and Future Market Potential of Ablation Technology Market in Global Industry: 2020 Research and New Innovations in Medical Devices Sector. The prime objective of the report is to offer updates and ...
PALO ALTO, Calif. , March 17, 2020 /PRNewswire/ -- Varian (NYSE: VAR) announced today, Proton International at UAB has now treated its first cancer patient with the Varian ProBeam ® Compact proton therapy system. The center, a collaboration between The University of Alaba...
PALO ALTO, Calif. , March 16, 2020 /PRNewswire/ -- Varian (NYSE: VAR) today announced it was selected to equip the new Ethos Personalized Adaptive Therapy Center in Phoenix, Arizona , and help launch a new era in cancer treatment for patients in the region. Ethos™ therapy pr...
PALO ALTO, Calif. , March 16, 2020 /PRNewswire/ -- Varian (NYSE: VAR) today announced its Halcyon ™ 2.0 treatment system has been approved by the China National Medical Products Administration (NMPA), which allows the company to market this cancer treatment system in China . This...
News, Short Squeeze, Breakout and More Instantly...
Varian Medical Systems Inc. Company Name:
VAR Stock Symbol:
NYSE Market:
Varian Medical Systems Inc. Website:
Varian Announces First Participant Treated in GENESIS II Clinical Trial of Genicular Artery Embolization for Knee Osteoarthritis PR Newswire PALO ALTO, Calif. , Nov. 17, 2022 /PRNewswire/ -- Varian, a Siemens Healthineers company, announced today that the...
Varian and the Cincinnati Children's/University of Cincinnati Medical Center Proton Therapy Center Announce Promising Results from FAST-01, First-in-Human Clinical Trial of Flash Therapy PR Newswire – Results published in JAMA Oncology and presented at ASTRO dem...